Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
The Journal of Health Management · 2026
DOI: 10.63719/johm.v23i1.238 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Health Management, 2026. Verfasst von Wen Yea Hwong und 8 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The significance of secondary preventive measures in reducing the burden of recurrent stroke is widely recognised. Yet, consolidated information on the prescription of secondary stroke prevention in low- and middle-income countries (LMICs) remains scarce. This review aimed to quantify the prescription of secondary preventive drugs among ischemic stroke (IS) and transient ischemic attack (TIA) patients in LMICs and explore potential factors that affect the prescription rates.
Methods
In this systematic review and meta-analysis, we searched PubMed/MEDLINE, EMBASE, Web of Science, and Global Index Medicus to identify studies published between 1 January 1996 and 15 April 2021. Observational studies conducted in LMICs that evaluated the prescription of antiplatelets, statins, antihypertensives, and oral anticoagulants after a stroke event with time points upon discharge, 3, 6, and 12 months were included. Meta-analyses of the included studies were conducted using a random-effects model. Effects from potential study and clinical characteristics were estimated with a meta-regression (PROSPERO ID: CRD42017056807).
Results
From 10,250 records, 62 articles comprising 248,747 IS/TIA patients were included. Pooled estimates at hospital discharge were 85.0% (95% CI: 79.0 – 90.0%) for antiplatelets, 62.0% (95% CI: 52.0 – 72.0%) for statins, 64.0% (95% CI: 58.0 – 71.0%) for antihypertensives, and 44.0% (95% CI: 29.0 – 59.0%) for anticoagulants among IS/TIA patients with atrial fibrillation. The prescription of secondary preventive drugs decreased with time from discharge. Variations between studies were associated with temporal trends, especially statins prescription, cardiovascular comorbidities in the prescription of statins and antihypertensives, study sizes, income level, and geographical differences.
Conclusion
The prescription of statins, antihypertensives, and oral anticoagulants for secondary stroke prevention remains inadequate in LMICs. This highlights the need for a multifaceted stroke preventive strategy that addresses essential components of secondary prevention.
Zitieren
APA
Hwong, W. Y., Lim, A. H., Lim, Y. M. F., Lim, M. T., Sivasampu, S., Selvarajah, S., Looi, I., Bots, M. L., & Vaartjes, I. (2026). Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. The Journal of Health Management. https://doi.org/10.63719/johm.v23i1.238
Vancouver
Hwong WY, Lim AH, Lim YMF, Lim MT, Sivasampu S, Selvarajah S, et al. Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. The Journal of Health Management. 2026. doi:10.63719/johm.v23i1.238
BibTeX
@article{Hwong2026,
author = {Hwong, Wen Yea and Lim, Audrey Huili and Lim, Yvonne Mei Fong and Lim, Ming Tsuey and Sivasampu, Sheamini and Selvarajah, Sharmini and Looi, Irene and Bots, Michiel L. and Vaartjes, Ilonca},
title = {Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis},
journal = {The Journal of Health Management},
year = {2026},
doi = {10.63719/johm.v23i1.238}
}
EUVIMED